Spruce Biosciences, Inc. (SPRB)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS

2001 JUNIPERO SERRA BLVD., SUITE 640 DALY CITY, CA 94104

Spruce Biosciences is a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with significant unmet need. Spruce is initially developing its wholly-owned product candidate, tildacerfont, as the potential first non-steroidal therapy for patients suffering from classic congenital adrenal hyperplasia (CAH). Classic CAH is a serious and life-threatening disease with no known novel therapies approved in approximately 50 years. Spruce is also developing tildacerfont for women suffering from a rare form of polycystic ovary syndrome (PCOS) with primary adrenal androgen excess, representing 3-5% of females with PCOS (estimated to be 150,000 to 200,000 patients in the United States).

Data as of 2021-08-02 09:17:32 -0400
Market Cap214.871 Million Shares Outstanding23.33 Million Avg 30-day Volume48.313 Thousand
P/E Ratio Dividend Yield EPS
Price/Sales Debt to Equity EBITDA
Price to Book Value0.0 Forward PE-4.43 Enterprise Value
Total Cash Current Debt Gross Profit
BETA0.0 52-week High/Low35.6 / 8.91 Next Earnings Date2021-08-11 Price to Cash FLow (P/CF) -26.4098
Data provided by IEX Cloud
View SEC Filings from SPRB instead.
Q1 2021 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 4 5 -20.0% 3 (0.18%) 3 (0.17%) 0.0%
Funds Holding: 41 46 -10.87% 14 (0.82%) 18 (1.04%) -22.22%
13F shares: 18.512 Million 18.523 Million -0.06% 8.252 Million 8.252 Million 0.01%
% Ownership 79.4456 79.7917 -0.43% 35.4146 35.5463 -0.37%
New Positions: 1 45 -97.78% 18
Increased Positions 15 3
Closed Positions 6 4
Reduced Positions 12 5
Total Calls
Total Puts
PUT/CALL Ratio
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding SPRB (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding SPRB BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

KING RICHARD CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
2,230 2021-06-30 3

GHARIB SAMIR M. CHIEF FINANCIAL OFFICER

  • Officer
1,412 2021-06-30 3

WAYS KIRK

  • Director
20,000 2021-06-23 2

SPIEGELMAN DANIEL K

  • Director
6,667 2021-05-20 2

GREY MICHAEL G EXECUTIVE CHAIRMAN

  • Officer
  • Director
10,000 2021-05-20 2

O'DONNELL NIALL

  • Director
10,000 2021-05-20 3

CHAYA MOGHRABI DINA

  • Director
10,000 2021-05-20 3

MURALIDHAR BALI

  • Director
10,000 2021-05-20 3

SIMPSON CAMILLA V

  • Director
11,673 2021-05-20 3

NOVO HOLDINGS A/S

  • 10% Owner
4,514,336 2021-05-19 3

DIAS SUBAWEERAGE CHIEF MEDICAL OFFICER

  • Officer
0 2021-01-28 2

RIVERVEST VENTURE FUND III, L.P.

RIVERVEST VENTURE FUND III (OHIO), L.P.

RIVERVEST VENTURE FUND IV, L.P.

  • 10% Owner
No longer subject to file 2020-10-14 2

HANSSON JONAS

  • Director
2,033,621 2020-10-14 2

HEALTHCAP VIII, L.P.

  • FORMER 10% OWNER
No longer subject to file 2020-10-14 2

OMEGA FUND VI, L.P.

OMEGA FUND VI GP MANAGER, LTD.

OMEGA FUND VI GP, L.P.

  • 10% Owner
  • FORMER 10% OWNER
No longer subject to file 2020-10-14 2

AYNECHI TIBA

  • Director
0 2020-10-08 1

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

GHARIB SAMIR M. - Officer CHIEF FINANCIAL OFFICER

2021-07-06 16:11:26 -0400 2021-06-30 J 1,412 $9.53 a 1,412 direct 2.6087 -1.0628 5.9903 3 -1.0628 6

KING RICHARD - Director - Officer CHIEF EXECUTIVE OFFICER

2021-07-06 16:12:02 -0400 2021-06-30 J 2,230 $9.53 a 2,230 direct 2.6087 -1.0628 5.9903 3 -1.0628 6

WAYS KIRK - Director

2021-06-25 16:21:54 -0400 2021-06-23 A 20,000 a 20,000 direct

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
SPRUCE BIOSCIENCES INC SPRB 2021-08-02 22:15:03 UTC -5.3605 5.4205 7000
SPRUCE BIOSCIENCES INC SPRB 2021-08-02 21:45:03 UTC -5.3912 5.4512 7000
SPRUCE BIOSCIENCES INC SPRB 2021-08-02 21:15:03 UTC -5.3912 5.4512 7000
SPRUCE BIOSCIENCES INC SPRB 2021-08-02 20:45:03 UTC -5.4348 5.4948 7000
SPRUCE BIOSCIENCES INC SPRB 2021-08-02 20:15:03 UTC -5.4348 5.4948 7000
SPRUCE BIOSCIENCES INC SPRB 2021-08-02 19:45:03 UTC -5.4348 5.4948 7000
SPRUCE BIOSCIENCES INC SPRB 2021-08-02 19:15:03 UTC -5.4348 5.4948 7000
SPRUCE BIOSCIENCES INC SPRB 2021-08-02 18:45:03 UTC -5.0699 5.1299 7000
SPRUCE BIOSCIENCES INC SPRB 2021-08-02 18:15:03 UTC -5.0699 5.1299 7000
SPRUCE BIOSCIENCES INC SPRB 2021-08-02 17:45:03 UTC -5.0699 5.1299 7000
SPRUCE BIOSCIENCES INC SPRB 2021-08-02 17:15:03 UTC -5.0699 5.1299 7000
SPRUCE BIOSCIENCES INC SPRB 2021-08-02 16:45:03 UTC -5.1714 5.2514 7000
SPRUCE BIOSCIENCES INC SPRB 2021-08-02 16:15:03 UTC -5.1714 5.2514 7000
SPRUCE BIOSCIENCES INC SPRB 2021-08-02 15:45:03 UTC -5.1714 5.2514 7000
SPRUCE BIOSCIENCES INC SPRB 2021-08-02 15:15:03 UTC -5.1714 5.2514 7000
SPRUCE BIOSCIENCES INC SPRB 2021-08-02 14:45:03 UTC -7.2324 7.3124 7000
SPRUCE BIOSCIENCES INC SPRB 2021-08-02 14:15:03 UTC -7.2324 7.3124 8000
SPRUCE BIOSCIENCES INC SPRB 2021-08-02 13:45:03 UTC -7.2324 7.3124 8000
SPRUCE BIOSCIENCES INC SPRB 2021-08-02 13:15:04 UTC -7.2324 7.3124 8000
SPRUCE BIOSCIENCES INC SPRB 2021-08-02 12:45:03 UTC -7.2324 7.3124 8000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments